Skip to main content

ImmunityBio, Inc 10-Q for FY2024 Q3

ImmunityBio, Inc. (IBRX)

10-Q 2024-11-12 For: 2024-09-30
View Original
Added on April 10, 2026

About this 10-Q

ImmunityBio, Inc filed this 10-Q on November 12, 2024, covering the quarter ended September 30, 2024 (FY2024 Q3).

Headline figures

Quarter ended September 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$6.11M
up 7346.3% from $82K a year earlier
Net loss
$85.73M
compared with a net loss of $95.58M a year earlier
Diluted EPS
-$0.14
compared with -$0.19 a year earlier